个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
郑光辉， 医学博士，主任技师，副教授，硕士生导师，北京天坛医院检验科微生物与分子遗传部长,国家药监局体外诊断试剂质量控制重点实验室副主任, 卫健委人才中心临床医学检验专业专家。2013年毕业于北京协和医学院，以第一或通讯作者发表SCI论文18篇，中文核心期刊论文13篇, 主持11项课题，获得国家卫建委医学人才培养计划、 北京市优秀人才“专项基金”，入选北京市医管局“青苗计划”，入选医管中心“培育计划”，获批北京科学技术协会“青年人才托举工程项目”，主持首都医科大学自然基金，主持首都医科大学大学生创新基金项目两项，获批国家重大新药创制项目合作成员，参与“863”国家重大新药创制项目等。以主要发明人（前三）申报并获批国家发明专利三项。获得北京市大学生优秀毕业设计指导教师奖，首都医科大学青年优秀教师奖，第十届中国微生物大会优秀论文一等奖，北京医学会检验医学分会青年论坛二等奖，中国医学装备协会检验医学分会优秀论文二等奖等。 目前担任“首都卫生发展项目”评审专家，《中华实验与临床病毒学杂志》审稿人，《国际检验医学杂志》审稿人，中国生物医学工程学会医检工程分会青年委员会副主任委员，北京医学会检验医学分会青年委员等十余项学术任职。
1. 2015年，北京天坛医院青年基金。基金号：2015-YQN-06
2. 2017年，“北京市优秀人才”青年骨干项目。基金号：2017000021469G270
3. 2018年，北京市医管局“青苗计划”项目。基金号：QML20180502
4. 2018年，首都医科大学本科生科研创新项目
5. 2019年，首都医科大学“培育计划”项目（PYZ19116）
6. 2019年，北京科学技术协会“青年人才托举工程项目”
7. 2020年，北京天坛医院自然基金（YZR-2020-15）
8. 2021年，首都医科大学本科生科研创新项目，基于HPLC-MS/MS的神经系统感染性疾病患者脑脊液代谢组学的研究，基金号：XSKY2021
9. 2021年，北京市医管中心“培育计划”。基金号：PX2022021
10. 2022年，国家卫生健康委医学人才培养计划,基金号：MTP2022A011.
[1]Zheng GH, Shen JJ, Zhan YC, et al. Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction[J]. Eur J Med Chem, 2014, 81:277-288. DOI: 10.1016/j.ejmech.2014.05.027.
[2]Zhang G, Zheng G, Zhang Y, et al. Evaluation of a micro/nanofluidic chip platform for the high-throughput detection of bacteria and their antibiotic resistance genes in post-neurosurgical meningitis[J]. Int J Infect Dis, 2018, 70:115-120. DOI: 10.1016/j.ijid.2018.03.012.
[3]Guanghui Z, Jing L, Guojun Z, et al. Epidemiology and risk factors of neurosurgical bacterial meningitis/encephalitis induced by carbapenem resistant Enterobacteriaceae[J]. J Infect Chemother, 2020, 26(1):101-106. DOI: 10.1016/j.jiac.2019.07.023.
[4]Qian L, Shi Y, Li F, et al. Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of External Ventricular and Lumbar Drainage-Associated Ventriculitis and Meningitis[J]. Front Microbiol, 2020, 11:596175. DOI: 10.3389/fmicb.2020.596175.
[5]Shi YJ, Zheng GH, Qian LY, et al. Longitudinal Analysis of Risk Factors for Clinical Outcomes of Enterobacteriaceae Meningitis/Encephalitis in Post-Neurosurgical Patients: A Comparative Cohort Study During 2014-2019[J]. Infect Drug Resist, 2020, 13:2161-2170. DOI: 10.2147/IDR.S252331.
[6]Zheng G, Ji X, Yu X, et al. Development and verification of a discriminate algorithm for diagnosing post-neurosurgical bacterial meningitis-A multicenter observational study[J]. J Clin Lab Anal, 2020, 34(2):e23069. DOI: 10.1002/jcla.23069.
[7]Zheng G, Li S, Zhao M, et al. Time to positive culture can differentiate post-neurosurgical coagulase-negative Staphylococci other than S epidermidis meningitis from contamination: A case-control observational study[J]. J Clin Lab Anal, 2020, 34(10):e23447. DOI: 10.1002/jcla.23447.
[8]Zheng G, Zhang Y, Zhang L, et al. Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study[J]. Sci Rep, 2020, 10(1):1568. DOI: 10.1038/s41598-020-58670-8.
[9]Ding Y, Shi Y, Wang L, et al. Potential biomarkers identified by TMT-based quantitative proteomics for diagnosis and classification of Guillain-Barré syndrome[J]. Eur J Neurol, 2021 . DOI: 10.1111/ene.15213.
[10]Hong L, Hongmei W, Leijie X, et al. Serum ceramide concentrations are associated with depression in patients after ischemic stroke-A two-center case-controlled study[J]. Clin Chim Acta, 2021, 518:110-115. DOI: 10.1016/j.cca.2021.03.014.
[11]Shi Y, Ding Y, Li G, et al. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics[J]. Front Immunol, 2021, 12:700031. DOI: 10.3389/fimmu.2021.700031.
[12]Sun B, Kang X, Yue S, et al. A rapid procedure for bacterial identification and antimicrobial susceptibility testing directly from positive blood cultures[J]. Analyst, 2021 . DOI: 10.1039/d1an01210j.
[13]Zheng G, Cao Y, Liu C, et al. Phenotype, molecular characterisation and risk factors for postoperative meningitis caused by ESBL-producing-Enterobacteriaceae: a six years multi-Centre comparative cohort study[J]. BMC Infect Dis, 2021, 21(1):85. DOI: 10.1186/s12879-021-05784-7.
[14]Zheng G, Zhang C, Zhang G, et al. Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis[J]. Infect Drug Resist, 2021, 14:2901-2909. DOI: 10.2147/IDR.S325635.
[15]Zheng G, Shi Y, Cao Y, et al. Clinical Feature, Therapy, Antimicrobial Resistance Gene Distribution, and Outcome of Nosocomial Meningitis Induced by Multidrug-Resistant Enterobacteriaceae-A Longitudinal Cohort Study From Two Neurosurgical Centers in Northern China[J]. Front Cell Infect Microbiol, 2022, 12:839257. DOI: 10.3389/fcimb.2022.839257.
[16]Zheng G, Wang S, Lv H, et al. Nomogram Analysis of Clinical Characteristics and Mortality Risk Factor of Non-Fermentative Gram-Negative Bacteria-Induced Post-Neurosurgical Meningitis[J]. Infect Drug Resist, 2022, 15:6379-6389. DOI: 10.2147/IDR.S385502.
[17]Sun J, Shi Y, Ding Y, et al. Effect of Follow-Up Cerebrospinal Fluid Cultures in Post-Neurosurgical Patients' Outcome with Gram-Negative Bacterial Meningitis/Encephalitis[J]. Infect Drug Resist, 2023, 16:6285-6295. DOI: 10.2147/IDR.S425799.
[18]Zheng G, Shi Y, Sun J, et al. Effect of antibiotic prophylaxis in the prognosis of Post-neurosurgical meningitis patients[J]. Eur J Med Res, 2023, 28(1):396. DOI: 10.1186/s40001-023-01399-7.
文件上传中...
